PlainVitamins

Candinex

by HoltraCeuticals · capsule · 120 capsules

  • On the market (NIH)
  • UPC 8 37654 80901 3
  • DSLD label 270857
  • Serving 2 to 6 capsules; amounts per 2 capsules
  • 60 servings

Candinex by HoltraCeuticals lists 9 ingredients, 9 with an amount per serving of 2 capsules, such as 240 mg of coconut oil powder, 240 mg of garlic powder, 200 mg of oregano powder extract and 200 mg of olive leaf extract. Its current label entered the NIH Dietary Supplement Label Database on July 21, 2022.

What is in Candinex?

Each row as the label prints it, per serving of 2 capsules. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Candinex: Supplement Facts rows against the market (DSLD label 270857, January 2026 release)
IngredientAmount% DVAmong products listing it
Coconut Oil powder240 mgCoconut oil in Candinex against 160 products0.24 g per serving; the middle half of products list 0.5 g to 2 g, the median 1 g.0.24 g

87% of 160 products listing coconut oil give more (median 1 g).

Garlic PowderGarlic Powder Note: deodorized240 mgGarlic in Candinex against 1,075 products240 mg per serving; the middle half of products list 50 mg to 500 mg, the median 200 mg.240 mg

Higher than 56% of 1,075 products listing garlic (median 200 mg).

Oregano Powder Extract200 mgOregano in Candinex against 302 products200 mg per serving; the middle half of products list 45 mg to 250 mg, the median 145 mg.200 mg

Higher than 65% of 302 products listing oregano (median 145 mg).

Olive leaf extract200 mgOlive in Candinex against 822 products200 mg per serving; the middle half of products list 30 mg to 300 mg, the median 100 mg.200 mg

Higher than 61% of 822 products listing olive (median 100 mg).

Grapefruit seed extract160 mgGrapefruit in Candinex against 220 products160 mg per serving; the middle half of products list 50 mg to 250 mg, the median 100 mg.160 mg

Higher than 65% of 220 products listing grapefruit (median 100 mg).

Uva Ursi extract120 mgUva Ursi in Candinex against 360 products120 mg per serving; the middle half of products list 25 mg to 206.25 mg, the median 100 mg.120 mg

Higher than 60% of 360 products listing uva ursi (median 100 mg).

Berberine Sulfate80 mgBerberine in Candinex against 419 products80 mg per serving; the middle half of products list 131.5 mg to 500 mg, the median 400 mg.80 mg

85% of 419 products listing berberine give more (median 400 mg).

Milk Thistle extract50 mgMilk Thistle in Candinex against 1,277 products50 mg per serving; the middle half of products list 90 mg to 300 mg, the median 175 mg.50 mg

83% of 1,277 products listing milk thistle give more (median 175 mg).

N-Acetyl L-Cysteine50 mgN-Acetyl Cysteine in Candinex against 1,259 products50 mg per serving; the middle half of products list 55 mg to 500 mg, the median 150 mg.50 mg

75% of 1,259 products listing N-acetyl cysteine give more (median 150 mg).

Source: NIH ODS Dietary Supplement Label Database, label 270857 (entered July 21, 2022), version 9.4.0. See the label on DSLD or its label image (PDF). Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

The rows in the top or bottom tenth of the products that list the same ingredient, and any above the adult upper limit at the most servings a day the directions give:

  • 83% of the 1,277 products that print an amount of milk thistle list more than its 50 mg of milk thistle (median 175 mg).

The NIH database records one serving a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

The products whose ingredient lists overlap most with Candinex's, rare ingredients counting for more.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Suggested use: 2-6 capsules per day or as a directed by your physician.
Warnings
Keep out of reach of children.
Warning: If you are under medical supervision, seek the advice of your physician or healthcare professional prior to use of this product.
Individuals with autoimmune conditions, depressive disorders, or pregnant/lactating women should consult their physician prior to use.
Storage
Store in a cool, dry place protected from light.

Source: label statements in DSLD label 270857.

What else is on the label?

Other ingredients: Gelatin, Rice Flour.

How many labels does Candinex have?

2 labels are on file under this name since March 25, 2013: other sizes, label designs and reformulations. The current one leads this page.

  1. Label 270857 (current) Entered July 21, 2022 · on the market · 120 capsules · UPC 8 37654 80901 3
  2. Label 19357 Entered March 25, 2013 · off the market November 23, 2021 · 120 capsules · UPC 8 37654 80901 3

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Kent Holtorf, MD and the Holtorf Medical Group, Inc. (distributor), El Segundo, CA. All HoltraCeuticals products.

Where next?